MYSM1 and Decreased total leukocyte count: Homozygous or compound heterozygous MYSM1 mutations in rare human patients result in an inherited bone marrow failure syndrome (IBMFS), characterized by anemia, leukopenia, and in some cases growth delay and mild developmental abnormalities1,5–7.